Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019–June 2021)

BACKGROUND: Pneumonia from SARS-CoV-2 is difficult to distinguish from other viral and bacterial etiologies. Broad-spectrum antimicrobials are frequently prescribed to patients hospitalized with COVID-19 which potentially acts as a catalyst for the development of antimicrobial resistance (AMR). OBJE...

Descripción completa

Detalles Bibliográficos
Autores principales: Kariyawasam, Ruwandi M., Julien, Danielle A., Jelinski, Dana C., Larose, Samantha L., Rennert-May, Elissa, Conly, John M., Dingle, Tanis C., Chen, Justin Z., Tyrrell, Gregory J., Ronksley, Paul E., Barkema, Herman W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899460/
https://www.ncbi.nlm.nih.gov/pubmed/35255988
http://dx.doi.org/10.1186/s13756-022-01085-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899460/
https://www.ncbi.nlm.nih.gov/pubmed/35255988
http://dx.doi.org/10.1186/s13756-022-01085-z

Ejemplares similares